Wang Luyao, Li Lianxin, Liu Jiaxin, Sheng Changting, Yang Maoyi, Hu Zhipeng, Yue Rensong
Department of Endocrinology, Hospital of Chengdu, University of Traditional Chinese Medicine, Chengdu, China.
Front Endocrinol (Lausanne). 2025 May 9;16:1499565. doi: 10.3389/fendo.2025.1499565. eCollection 2025.
Type 2 diabetes mellitus(T2DM) as a common chronic disease with an increasing prevalence worldwide that poses a great threat to individual health, and is characterized by chronic hyperglycemia resulting from insulin resistance (IR) coupled with β-cell dysfunction. Mitochondrial dysfunction, obesity, gut microbiota, oxidative stress and inflammation have emerged as a significant contributor to the etiology of T2DM, affecting various metabolic processes critical for glucose homeostasis. This short review underscores their role in enhancing T2DM-related molecular mechanisms and explores recent advancements in diabetic management, further highlights the importance of personalized care plans to address the complexities of the T2DM and aims to improve patient quality of life and long-term health outcome.
2型糖尿病(T2DM)是一种常见的慢性病,在全球范围内患病率不断上升,对个人健康构成巨大威胁,其特征是胰岛素抵抗(IR)伴β细胞功能障碍导致的慢性高血糖。线粒体功能障碍、肥胖、肠道微生物群、氧化应激和炎症已成为T2DM病因的重要因素,影响着对葡萄糖稳态至关重要的各种代谢过程。这篇简短的综述强调了它们在增强T2DM相关分子机制中的作用,并探讨了糖尿病管理的最新进展,进一步强调了个性化护理计划对于应对T2DM复杂性的重要性,旨在提高患者的生活质量和长期健康结果。